SEC Form 4 · accession 0001104659-26-104739
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren Sherman
Officer — See Remarks · Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001814114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock")F2 | Sep 1, 2026 | S | 15,000 | $4.94 | D | 1,134,402 | D | |
| Common StockF3 | holding | — | — | — | 2,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.
- F2The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.
- F3The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Remarks
President and Chief Operating Officer